Clinical Trial Update: Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice [Phase 3]

View source ↗

Summary

Phase 3 clinical study investigating a novel dentifrice for dentin hypersensitivity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dentin Hypersensitivity

Drugs mentioned

• Novel dentifrice (HALEON sponsor)

Snippet

Sponsor: HALEON | Conditions: Dentin Hypersensitivity | Phase 3 | Status: COMPLETED